Could it Be? Sanofi-Genzyme, for $74 per share
Madoff Speaks: The Ponzi schemer insists banks had to know of fraud, the Wilpons knew nothing. Reportedly, this is the tip of the iceberg of stuff the Wilpons knew nothing about.
R&D Down & Out? Merck’s Dutch R&D unit has no offer, faces shuttering
Stocks: Foreign markets bode well for U.S. futures, which are also up
“Balls to the wall, long and short with no hedging”: SAC’s Steven Cohen speaks in NYC
Funding: Doxo gets $10M Series B